Interaction between host G3BP and viral nucleocapsid protein regulates SARS-CoV-2 replication and pathogenicity.

CP: Microbiology G3BP NTF2L domain SARS-CoV-2 replication and pathogenesis host-pathogen interaction nucleocapsid protein stress granule vRNA sequestration

Journal

Cell reports
ISSN: 2211-1247
Titre abrégé: Cell Rep
Pays: United States
ID NLM: 101573691

Informations de publication

Date de publication:
14 Mar 2024
Historique:
received: 26 09 2023
revised: 29 01 2024
accepted: 28 02 2024
medline: 16 3 2024
pubmed: 16 3 2024
entrez: 16 3 2024
Statut: aheadofprint

Résumé

G3BP1/2 are paralogous proteins that promote stress granule formation in response to cellular stresses, including viral infection. The nucleocapsid (N) protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) inhibits stress granule assembly and interacts with G3BP1/2 via an ITFG motif, including residue F17, in the N protein. Prior studies examining the impact of the G3PB1-N interaction on SARS-CoV-2 replication have produced inconsistent findings, and the role of this interaction in pathogenesis is unknown. Here, we use structural and biochemical analyses to define the residues required for G3BP1-N interaction and structure-guided mutagenesis to selectively disrupt this interaction. We find that N-F17A mutation causes highly specific loss of interaction with G3BP1/2. SARS-CoV-2 N-F17A fails to inhibit stress granule assembly in cells, has decreased viral replication, and causes decreased pathology in vivo. Further mechanistic studies indicate that the N-F17-mediated G3BP1-N interaction promotes infection by limiting sequestration of viral genomic RNA (gRNA) into stress granules.

Identifiants

pubmed: 38492217
pii: S2211-1247(24)00293-6
doi: 10.1016/j.celrep.2024.113965
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

113965

Informations de copyright

Copyright © 2024 The Author(s). Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of interests J.P.T. is a consultant for Nido Biosciences. V.D.M. has filed a patent on the reverse genetic system and reporter SARS-CoV-2.

Auteurs

Zemin Yang (Z)

Department of Cell and Molecular Biology, St. Jude Children's Research Hospital, Memphis, TN, USA; Integrated Biomedical Sciences Program, University of Tennessee Health Science Center, Memphis, TN, USA.

Bryan A Johnson (BA)

Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USA; Institute for Human Infection and Immunity, University of Texas Medical Branch, Galveston, TX, USA; Center for Tropical Diseases, University of Texas Medical Branch, Galveston, TX, USA.

Victoria A Meliopoulos (VA)

Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, TN, USA.

Xiaohui Ju (X)

School of Medicine, Tsinghua University, Beijing, China.

Peipei Zhang (P)

Department of Cell and Molecular Biology, St. Jude Children's Research Hospital, Memphis, TN, USA.

Michael P Hughes (MP)

Department of Cell and Molecular Biology, St. Jude Children's Research Hospital, Memphis, TN, USA.

Jinjun Wu (J)

Department of Cell and Molecular Biology, St. Jude Children's Research Hospital, Memphis, TN, USA; Integrated Biomedical Sciences Program, University of Tennessee Health Science Center, Memphis, TN, USA.

Kaitlin P Koreski (KP)

Department of Cell and Molecular Biology, St. Jude Children's Research Hospital, Memphis, TN, USA.

Jemma E Clary (JE)

Department of Cell and Molecular Biology, St. Jude Children's Research Hospital, Memphis, TN, USA.

Ti-Cheng Chang (TC)

Center for Applied Bioinformatics, St. Jude Children's Research Hospital, Memphis, TN, USA.

Gang Wu (G)

Center for Applied Bioinformatics, St. Jude Children's Research Hospital, Memphis, TN, USA.

Jeff Hixon (J)

Faze Medicines, Cambridge, MA, USA.

Jay Duffner (J)

Faze Medicines, Cambridge, MA, USA.

Kathy Wong (K)

Faze Medicines, Cambridge, MA, USA.

Rene Lemieux (R)

Faze Medicines, Cambridge, MA, USA.

Kumari G Lokugamage (KG)

Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USA.

R Elias Alvarado (RE)

Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USA.

Patricia A Crocquet-Valdes (PA)

Department of Pathology, University of Texas Medical Branch, Galveston, TX, USA.

David H Walker (DH)

Department of Pathology, University of Texas Medical Branch, Galveston, TX, USA.

Kenneth S Plante (KS)

Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USA; World Reference Center for Emerging Viruses and Arboviruses, University of Texas Medical Branch, Galveston, TX, USA.

Jessica A Plante (JA)

Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USA; World Reference Center for Emerging Viruses and Arboviruses, University of Texas Medical Branch, Galveston, TX, USA.

Scott C Weaver (SC)

Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USA; Institute for Human Infection and Immunity, University of Texas Medical Branch, Galveston, TX, USA; World Reference Center for Emerging Viruses and Arboviruses, University of Texas Medical Branch, Galveston, TX, USA.

Hong Joo Kim (HJ)

Department of Cell and Molecular Biology, St. Jude Children's Research Hospital, Memphis, TN, USA.

Rachel Meyers (R)

Faze Medicines, Cambridge, MA, USA.

Stacey Schultz-Cherry (S)

Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, TN, USA.

Qiang Ding (Q)

School of Medicine, Tsinghua University, Beijing, China.

Vineet D Menachery (VD)

Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USA; World Reference Center for Emerging Viruses and Arboviruses, University of Texas Medical Branch, Galveston, TX, USA. Electronic address: vimenach@utmb.edu.

J Paul Taylor (JP)

Department of Cell and Molecular Biology, St. Jude Children's Research Hospital, Memphis, TN, USA; Howard Hughes Medical Institute, Chevy Chase, MD, USA. Electronic address: jpaul.taylor@stjude.org.

Classifications MeSH